When is a scientific study not a scientific study? That was a question posed by several panelists during a two-hour session on medication Jan. 25 during the National HBPA winter convention.
Scientific and regulatory advisers to the National Horsemen's Benevolent and Protective Association July 13 expressed concerns over the proposed withdrawal time and testing level for the bronchodilator clenbuterol.
As McKinsey & Company prepares for The Jockey Club a broad report on Thoroughbred racing, a horsemen's group has reviewed a medication study the company authored 20 years ago.
The Kentucky Horse Racing Commission's Equine Drug Research Council has withdrawn support and funding for one of six projects that it had approved for 2010.
Six equine research projects totaling nearly $400,000 over a two-year period have been approved by the Kentucky Horse Racing Commission following a recommendation from the Equine Drug Research Council.
California will soon release the results of a study that will reflect trends in connection with blood samples taken from about 6,000 racehorses for the purpose of "milkshake" --or TCO2 testing-- last year.
The National Horsemen's Benevolent and Protective Association Medication Committee will review California research that helped develop thresholds for two therapeutic medications during its meeting July 14 in Bloomington, Minn., as part of the National HBPA summer convention.
Representatives of affiliates of the National Horsemen's Benevolent and Protective Association indicated Jan. 22 they support uniformity in medication and drug testing but need clear guidelines and consistent interpretation of the rules by sometimes overzealous regulators and stewards.
Racing New South Wales stewards opened an inquiry on Monday into the analyst's finding of benzoylecgonine, a metabolite of cocaine, in the urine sample taken from the 3-year-old filly Love You Honey, who finished unplaced in race seven April 25, 2005, at Gosford Racecourse in Australia.
The University of Kentucky's equine drug research program, funded by pari-mutuel handle under the auspices of the Kentucky Horse Racing Authority, apparently has been suspended indefinitely.
The Kentucky Racing Commission has approved an agreement with the University of Kentucky for the college to apply for accreditation of its Animal Drug Testing Program and better monitor projects and control related costs.
Two bills introduced in the Kentucky legislature would permit officials to spend money on drug research pertinent to the horse racing and breeding industries out of state if they so desire. Current statute mandates the money stay at Kentucky research facilities.
A campaign to bring about changes in equine drug research in Kentucky has spilled over into the public and political arenas with a call for legislative action.
The Kentucky Racing Commission, apparently at the urging of the state Equine Drug Council, has hired Dr. Richard Sams of Ohio State University to serve as a consultant on medication and drug-testing issues.
In the wake of a Jan. 28 teleconference to discuss plans for a national medication policy, organizers and the National Horsemen's Benevolent and Protective Association continue to negotiate on a representation issue.
Kentucky's Equine Drug Council has identified research into furosemide (Salix) use and quantification as the top priority for 2002, but the council on Wednesday decided proposed research projects and its budget for next year required further review.
The second round of "super-test" results from the National Thoroughbred Racing Association Racing Integrity and Drug Testing Task Force should be released early in January, said Jim Gallagher, executive director of the task force.
Researchers at the University of Kentucky Gluck Equine Center have made significant progress in their quest to find the cause of the Mare Reproductive Loss Syndrome. According to reports presented Thursday during an informational forum at Keeneland, black cherry trees located in close proximity to horse pastures are the primary source of the cyanide that was detected in tests of dead foals and fetuses from mares that aborted.
Samples collected from horses that breezed at the Fasig-Tipton Calder under-tack show Feb. 18 contained no performance-enhancing medication, test results showed.
The sale company will test selected horses as they exit the racetrack after under-tack breezes.
Most Popular Stories
- First Reported Foal for Rattlesnake Bridge
- Through the Lens: Wise Dan Photo Gets Award
- Final Call for Taylors of Seattle Slew Fame
- Australian Vets Support New Racing Rule on Cobalt
- 'Chrome' Tops U.S. Nominees for World Cup
- Subjective vs. Objective Lameness Identification Methods
- Jockey Chapa Faces Felony Race-Fixing Charges
- New Leadership Coming for Illinois Board
- Flashy Performances at OBS Day of Champions
- Steve Haskin's Derby Dozen for Jan. 27, 2015